UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.88 Million Stake in Cellebrite DI Ltd. (NASDAQ:CLBT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT) by 11.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 111,791 shares of the company’s stock after purchasing an additional 11,730 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Cellebrite DI were worth $1,883,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Telemark Asset Management LLC acquired a new position in shares of Cellebrite DI in the third quarter valued at $6,736,000. Scalar Gauge Management LLC raised its stake in shares of Cellebrite DI by 15.2% in the 2nd quarter. Scalar Gauge Management LLC now owns 453,554 shares of the company’s stock valued at $5,420,000 after buying an additional 60,000 shares in the last quarter. Connors Investor Services Inc. bought a new position in shares of Cellebrite DI during the 2nd quarter worth about $1,803,000. Principal Financial Group Inc. acquired a new stake in shares of Cellebrite DI during the 3rd quarter valued at about $23,402,000. Finally, Concurrent Investment Advisors LLC bought a new stake in Cellebrite DI in the second quarter valued at about $835,000. 45.88% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CLBT has been the subject of a number of recent research reports. Craig Hallum increased their target price on Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $21.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, November 7th. Needham & Company LLC boosted their target price on shares of Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Finally, TD Cowen increased their target price on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Cellebrite DI currently has a consensus rating of “Buy” and an average target price of $20.29.

Cellebrite DI Trading Down 0.8 %

CLBT opened at $19.88 on Monday. The stock’s fifty day simple moving average is $18.93 and its 200 day simple moving average is $15.78. Cellebrite DI Ltd. has a 1-year low of $7.91 and a 1-year high of $21.72. The stock has a market cap of $4.09 billion, a PE ratio of -12.83, a price-to-earnings-growth ratio of 2.71 and a beta of 1.51.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.05. The business had revenue of $106.90 million during the quarter, compared to analysts’ expectations of $102.06 million. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period last year, the firm posted $0.09 EPS. Equities analysts forecast that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.